Kronos Bio, Inc.
🏢 View company profile →10Patents
10Active
10Granted
50Portfolio score
Filing activity: Aug 10, 2018 → Nov 18, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10842803B2 | Imidazopyridines Syk inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10828299B2 | Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine | Chemistry; Metallurgy | 3 | Active |
| US12152037B2 | Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor | Chemistry; Metallurgy | 1 | Active |
| US11384082B2 | Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11339168B2 | Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11517570B2 | Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine | Chemistry; Metallurgy | 1 | Active |
| US11155560B2 | Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity | Chemistry; Metallurgy | 0 | Active |
| US11845754B2 | Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity | Chemistry; Metallurgy | 0 | Active |
| US12263163B2 | Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor | Chemistry; Metallurgy | 0 | Active |
| US12122781B2 | Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.